findmyKOL
Clinical trialNCT04968834RecruitingObservational

Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens

SponsorDana-Farber Cancer InstituteEnrollment300LeukemiaMyelodysplastic SyndromesMyeloproliferative Syndrome
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This research study is a genomic profiling and repository study for children and young adults who have leukemia, myelodysplastic syndrome (MDS) or myeloproliferative syndrome (MPS). Genes are the part of cells that contain the instructions which tell cells how to make the right proteins to grow and work. Genes are composed of DNA letters that spell out these instructions. Genomic profiling helps investigators understand why the disease develops and the instructions that led to its development. Understanding the genetic factors of the disease can also help investigator understand why the disease of some people can respond to certain therapies differently than others. The genomic profiling will be performed using bone marrow and blood samples that either have already been obtained during a previous clinical procedure or will be obtained at the time of a scheduled clinical procedure. Studying the genetic information in the cells of these samples will provide information about the origin, progression, and treatment of leukemia and myeloproliferative syndromes and myelodysplastic syndrome. Storing the bone marrow and blood samples will allow for additional research and genomic assessments to be performed in the future.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Connecticut Children'S Medical Center

    Hartford, Connecticut, United States

    Recruiting
  • Maine Medical Center

    Portland, Maine, United States

    Recruiting
  • Boston Children'S Hospital

    Boston, Massachusetts, United States

    Active, not recruiting
  • Dana Farber Cancer Institute

    Boston, Massachusetts, United States

    Active, not recruiting
  • Dartmouth-Hitchcock

    Lebanon, New Hampshire, United States

    Recruiting
  • Albany Medical Center

    Albany, New York, United States

    Recruiting
  • Lifespan Cancer Institute

    Providence, Rhode Island, United States

    Recruiting
  • University of Vermont Medical Center

    Burlington, Vermont, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
11 Jun 2021
Primary completion
30 Jun 2033
Completion
30 Jun 2033
Last update posted
16 Jul 2026
Registered enrollment
300
Registry id
NCT04968834

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.